Dr. Donald E. Cutlip, MD

Dr. Cutlip practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Cutlip's NPI, 1396777827, was assigned on July 7, 2006. Dr. Cutlip graduated from University of South Florida College of Medicine in 1979. Dr. Cutlip holds Massachusetts license 78140.

Dr. Cutlip's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Cutlip's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Dr. Cutlip is also affiliated with Beth Israel Deaconess Hospital-Needham. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Cutlip to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cutlip practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Cutlip's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Cutlip is licensed in Massachusetts.

CMS data shows 791 Medicare services from Dr. Cutlip across 11 procedure codes in 2024, for 502 Medicare patients. Medicare paid $58,329 for them.

CMS counts 502 Medicare patients who saw Dr. Cutlip in 2024. The largest group is 75 to 84, with 209 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cutlip's median patient age at 74, with 42% women.

In 2024, Dr. Cutlip wrote 841 Medicare Part D claims for 100 patients. 86% of them were for generic drugs. CMS names the drug for 760 of them, across 21 drugs with 11 or more claims each, at $115,315 in total drug cost. In 2023, CMS named 699 claims across 21 drugs.

Dr. Cutlip accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cutlip as offering telehealth.

Dmand AI links 62 papers to Dr. Cutlip, published from 2016 to 2025. 2017 was the busiest year, with 8. The most frequent topics are Percutaneous Coronary Intervention, Coronary Artery Disease and Drug-Eluting Stents. Dr. Cutlip has published most often in Circ Cardiovasc Interv. Dr. Cutlip's most frequent co-authors are Mitchell W. Krucoff, MD, Robert Wayne Yeh, MD and Roxana Mehran, MD.

CMS Open Payments shows 28 general payments to Dr. Cutlip from 9 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 34% of the total. CeloNova BioSciences, Inc. paid the most, $9,462.

Dr. Cutlip graduated from University of South Florida College of Medicine in 1979.